Abstract

Protein kinase N1 (PKN1) knockout (KO) mice spontaneously form germinal centers (GCs) and develop an autoimmune-like disease with age. Here, we investigated the function of PKN1 kinase activity in vivo using aged mice deficient in kinase activity resulting from the introduction of a point mutation (T778A) in the activation loop of the enzyme. PKN1[T778A] mice reached adulthood without external abnormalities; however, the average spleen size and weight of aged PKN1[T778A] mice increased significantly compared to aged wild type (WT) mice. Histologic examination and Southern blot analyses of spleens showed extramedullary hematopoiesis and/or lymphomagenesis in some cases, although without significantly different incidences between PKN1[T778A] and WT mice. Additionally, flow cytometry revealed increased numbers in B220+, CD3+, Gr1+ and CD193+ leukocytes in the spleen of aged PKN1[T778A] mice, whereas the number of lymphocytes, neutrophils, eosinophils, and monocytes was reduced in the peripheral blood, suggesting an advanced impairment of leukocyte trafficking with age. Moreover, aged PKN1[T778A] mice showed no obvious GC formation nor autoimmune-like phenotypes, such as glomerulonephritis or increased anti-dsDNA antibody titer, in peripheral blood. Our results showing phenotypic differences between aged Pkn1-KO and PKN1[T778A] mice may provide insight into the importance of PKN1-specific kinase-independent functions in vivo.

Details

Title
PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes
Author
Salman Mahmud Siddique 1 ; Kubouchi, Koji 1 ; Shinmichi, Yuka 2 ; Sawada, Nana 2 ; Sugiura, Reiko 2 ; Itoh, Yasushi 3 ; Uehara, Shunsuke 4 ; Nishimura, Kanae 5 ; Okamura, Shunsuke 5 ; Ohsaki, Hiroyuki 5   VIAFID ORCID Logo  ; Kamoshida, Shingo 5 ; Yamashita, Yusuke 6 ; Tamura, Shinobu 6 ; Sonoki, Takashi 6 ; Matsuoka, Hiroshi 7 ; Itoh, Tomoo 8 ; Mukai, Hideyuki 9 

 Graduate School of Medicine, Kobe University, Kobe, Japan 
 Laboratory of Molecular Pharmacogenomics, School of Pharmaceutical Sciences, Kindai University, Higashi-Osaka, Japan 
 Department of Pathology, Shiga University of Medical Science, Otsu, Shiga, Japan 
 Department of Biochemistry, Matsumoto Dental University, Shiojiri, Nagano, Japan 
 Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Hyogo, Japan 
 Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan 
 Division of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Hyogo, Japan 
 Department of Diagnostic Pathology, Kobe University Hospital, Kobe, Hyogo, Japan 
 Graduate School of Medicine, Kobe University, Kobe, Japan; Biosignal Research Center, Kobe University, Kobe, Japan 
Pages
1-14
Publication year
2019
Publication date
Sep 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2298762354
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.